602 related articles for article (PubMed ID: 26996412)
1. Prion-like domains as epigenetic regulators, scaffolds for subcellular organization, and drivers of neurodegenerative disease.
March ZM; King OD; Shorter J
Brain Res; 2016 Sep; 1647():9-18. PubMed ID: 26996412
[TBL] [Abstract][Full Text] [Related]
2. RNA-binding proteins with prion-like domains in health and disease.
Harrison AF; Shorter J
Biochem J; 2017 Apr; 474(8):1417-1438. PubMed ID: 28389532
[TBL] [Abstract][Full Text] [Related]
3. Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains.
Guo L; Kim HJ; Wang H; Monaghan J; Freyermuth F; Sung JC; O'Donovan K; Fare CM; Diaz Z; Singh N; Zhang ZC; Coughlin M; Sweeny EA; DeSantis ME; Jackrel ME; Rodell CB; Burdick JA; King OD; Gitler AD; Lagier-Tourenne C; Pandey UB; Chook YM; Taylor JP; Shorter J
Cell; 2018 Apr; 173(3):677-692.e20. PubMed ID: 29677512
[TBL] [Abstract][Full Text] [Related]
4. The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.
King OD; Gitler AD; Shorter J
Brain Res; 2012 Jun; 1462():61-80. PubMed ID: 22445064
[TBL] [Abstract][Full Text] [Related]
5. Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.
Guo L; Shorter J
Cold Spring Harb Perspect Med; 2017 Sep; 7(9):. PubMed ID: 27920024
[TBL] [Abstract][Full Text] [Related]
6. From Prions to Stress Granules: Defining the Compositional Features of Prion-Like Domains That Promote Different Types of Assemblies.
Fomicheva A; Ross ED
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513942
[TBL] [Abstract][Full Text] [Related]
7. Engineered protein disaggregases mitigate toxicity of aberrant prion-like fusion proteins underlying sarcoma.
Ryan JJ; Sprunger ML; Holthaus K; Shorter J; Jackrel ME
J Biol Chem; 2019 Jul; 294(29):11286-11296. PubMed ID: 31171724
[TBL] [Abstract][Full Text] [Related]
8. Engineering enhanced protein disaggregases for neurodegenerative disease.
Jackrel ME; Shorter J
Prion; 2015; 9(2):90-109. PubMed ID: 25738979
[TBL] [Abstract][Full Text] [Related]
9. Disease mutations in the prion-like domains of hnRNPA1 and hnRNPA2/B1 introduce potent steric zippers that drive excess RNP granule assembly.
Shorter J; Taylor JP
Rare Dis; 2013; 1():e25200. PubMed ID: 25002999
[TBL] [Abstract][Full Text] [Related]
10. Composition-based prediction and rational manipulation of prion-like domain recruitment to stress granules.
Boncella AE; Shattuck JE; Cascarina SM; Paul KR; Baer MH; Fomicheva A; Lamb AK; Ross ED
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5826-5835. PubMed ID: 32127480
[TBL] [Abstract][Full Text] [Related]
11. Transportin 1 accumulates specifically with FET proteins but no other transportin cargos in FTLD-FUS and is absent in FUS inclusions in ALS with FUS mutations.
Neumann M; Valori CF; Ansorge O; Kretzschmar HA; Munoz DG; Kusaka H; Yokota O; Ishihara K; Ang LC; Bilbao JM; Mackenzie IR
Acta Neuropathol; 2012 Nov; 124(5):705-16. PubMed ID: 22842875
[TBL] [Abstract][Full Text] [Related]
12. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS.
Kim HJ; Kim NC; Wang YD; Scarborough EA; Moore J; Diaz Z; MacLea KS; Freibaum B; Li S; Molliex A; Kanagaraj AP; Carter R; Boylan KB; Wojtas AM; Rademakers R; Pinkus JL; Greenberg SA; Trojanowski JQ; Traynor BJ; Smith BN; Topp S; Gkazi AS; Miller J; Shaw CE; Kottlors M; Kirschner J; Pestronk A; Li YR; Ford AF; Gitler AD; Benatar M; King OD; Kimonis VE; Ross ED; Weihl CC; Shorter J; Taylor JP
Nature; 2013 Mar; 495(7442):467-73. PubMed ID: 23455423
[TBL] [Abstract][Full Text] [Related]
13. Natural and pathogenic protein sequence variation affecting prion-like domains within and across human proteomes.
Cascarina SM; Ross ED
BMC Genomics; 2020 Jan; 21(1):23. PubMed ID: 31914925
[TBL] [Abstract][Full Text] [Related]
14. Perfecting prediction of mutational impact on the aggregation propensity of the ALS-associated hnRNPA2 prion-like protein.
Batlle C; Fernández MR; Iglesias V; Ventura S
FEBS Lett; 2017 Jul; 591(13):1966-1971. PubMed ID: 28542905
[TBL] [Abstract][Full Text] [Related]
15. Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain.
Boulay G; Sandoval GJ; Riggi N; Iyer S; Buisson R; Naigles B; Awad ME; Rengarajan S; Volorio A; McBride MJ; Broye LC; Zou L; Stamenkovic I; Kadoch C; Rivera MN
Cell; 2017 Sep; 171(1):163-178.e19. PubMed ID: 28844694
[TBL] [Abstract][Full Text] [Related]
16. De novo design of RNA-binding proteins with a prion-like domain related to ALS/FTD proteinopathies.
Mitsuhashi K; Ito D; Mashima K; Oyama M; Takahashi S; Suzuki N
Sci Rep; 2017 Dec; 7(1):16871. PubMed ID: 29203801
[TBL] [Abstract][Full Text] [Related]
17. The prion-like protein kinase Sky1 is required for efficient stress granule disassembly.
Shattuck JE; Paul KR; Cascarina SM; Ross ED
Nat Commun; 2019 Aug; 10(1):3614. PubMed ID: 31399582
[TBL] [Abstract][Full Text] [Related]
18. Biochemical Properties and Biological Functions of FET Proteins.
Schwartz JC; Cech TR; Parker RR
Annu Rev Biochem; 2015; 84():355-79. PubMed ID: 25494299
[TBL] [Abstract][Full Text] [Related]
19. Role of FET proteins in neurodegenerative disorders.
Svetoni F; Frisone P; Paronetto MP
RNA Biol; 2016 Nov; 13(11):1089-1102. PubMed ID: 27415968
[TBL] [Abstract][Full Text] [Related]
20. Manipulating the aggregation activity of human prion-like proteins.
Cascarina SM; Paul KR; Ross ED
Prion; 2017 Sep; 11(5):323-331. PubMed ID: 28934062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
